Monday, January 29, 2007

Lucentis (For Macular Degeneration): Increases Stroke Risk

Genentech Inc. alerted eye doctors late last week to the risk of stroke from Lucentis. The drug is used to treat age related macular degeneration. According to AHAF, Age-related macular degeneration (AMD) is a common eye disease that causes deterioration of the macula, the central area of the retina, the paper-thin tissue at the back of the eye where light-sensitive cells send visual signals to the brain.

The company will probably change the drug label soon.